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Abstract
Background: Arterial tortuosity syndrome (ATS) (OMIM #208050) is a rare autosomal recessive
connective tissue disorder characterized by tortuosity and elongation of the large and medium-
sized arteries, propensity to aneurysms formation, vascular dissection, and pulmonary arteries
stenosis. ATS is caused by mutations in SLC2A10 gene, encoding for the facilitative glucose
transporter 10 (GLUT10). So far, 17 SLC2A10 mutations have been reported in 32 families, two of
which were Italian with a total of five patients. Here we present the clinical and molecular
characterization of two novel Italian paediatric ATS patients.
Methods: The exons and intronic flanking regions of SLC2A10 gene were amplified and direct
sequencing was performed.
Results: In both patients, the involvement of major- and medium-sized arteries was characteristic;
the nonvascular connective tissue manifestations were mild and not pathognomic of the disorder.
Both patients, born from non-consanguineous parents, were heterozygous for two different
SLC2A10 mutations, three of which were recurrent and one was novel (p.Arg231Trp). This
mutation is localized at the endofacial loop between the transmembrane domains 6 and 7 of
GLUT10.
Conclusion: Two novel ATS patients were characterized at clinical and molecular level. Overall,
four ATS unrelated families are known in Italy so far. Though ATS clinical delineation improved in
the last years, further works in the comprehension of disease presentation and complications
onset, particularly in paediatric age, and on ATS molecular basis are needed to add new insights for
diagnosis and prevention strategies for related complications.
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Arterial tortuosity syndrome (ATS) (OMIM #208050) is
an extremely rare autosomal recessive disorder character-
ized by tortuosity and elongation of the large and
medium-sized arteries, propensity to aneurysms forma-
tion, vascular dissection, and pulmonary arteries stenosis.
Other typical manifestations are dysmorphic features,
hyperextensible skin, cutis laxa, herniae, skeletal abnor-
malities, joints hypermobility, and congenital contrac-
tures [1-4]. ATS is due to mutations in SLC2A10 gene,
located on chromosome 20q13.1 and encoding for the
541 amino acid facilitative glucose transporter 10
(GLUT10), consisting in 12 transmembrane hydrophobic
segments connected by 5 intracellular and 6 extracellular
loops [5,6]. So far, 17 SLC2A10 mutations have been
reported in 32 ATS families [3-5,7,8]. In this work we
report the clinical findings and the molecular characteri-
zation of two Italian paediatric ATS patients.
Case presentation
Patient 1, an eight-months-old male baby, is the second-
born from non-consanguineous unaffected parents. He
was born by cesarean section for malposition at the 36th
week of gestation after a pregnancy complicated by oli-
goidramnios. At birth, his weight was 2.680 g and Apgar
index of 7 and 8 at 1 and 5 minutes, respectively. Because
progressive signs of respiratory distress (i.e., tachypnea
and SatO2 of 83%) were noted soon after birth and given
the presence of crackles at lung auscultation, antibiotic
therapy and continuous positive airway pressure were
started. Subsequently, the patient required synchronized
intermittent mandatory ventilation with a FiO2 of about
45%-50% and was extubated after 8 days. Chest radiogra-
phy, cranial and abdominal ultrasounds were normal.
Cardiac echography showed a normal heart anatomy, but
the presence of pulmonary hypertension signs and
marked tortuosity of aortic arch. Magnetic Resonance
Angiography (MRA) was needed (Figure 1,i). So far, stat-
uro-ponderal growth is normal and, except facial dysmor-
phisms (Figure 1,ii), no cutaneous or skeletal
involvement is noted. At six months the patient under-
went to hernioplasty for bilateral congenital scrotal-
inguinal hernia without post-surgery complications. At 7
month the patient was hospitalized for bronchiolitis and
respiratory instability.
Patient 2, a five-years-old child, is the first of two sons of
healthy non-consanguineous parents of South Italy ori-
gins. He came to medical attention, without a previous
significant clinical history, at four years, for sudden dysp-
noea and asthenia during a usual activity. Echocardiogra-
phy excluded heart disease and showed pulmonary
hypertension; angiography disclosed severe stenoses,
elongation, and tortuosity of pulmonary arteries
branches, aortic arch, sovraortic trunks, and iliac arteries.
Pulmonary hypertension treatment was carried out as pre-
viously reported [10]. Patient's extravascular findings
were: facial features (Figure 1, iii), high-arched palate, sco-
liosis, pectus excavatum, and joints hypermobility. No
cutaneous, ocular, or tegument involvement was
observed.
Radiographic and facial features of the two PatientsFigure 1
Radiographic and facial features of the two Patients. 
i) MRA of Patient 1 showed tortuosity and kinking of aortic 
arch, mild hypoplasia of descending and abdominal aorta, tor-
tuosity of all the sovraortic trunks with kinking of left com-
mon carotid and left subclavian arteries, ectasia of the 
innominate artery origin, and bilateral reduction of periph-
eral pulmonary branches. ii) Patient 1 showed elongated face, 
micrognathia, mild blepharophimosis, downslanting palpebral 
fissures, beaked nose, high-arched palate. iii) Patient 2 
showed elongated face, low-set and anteverted ears, down-
slanting palpebral fissures, high nasal bridge.Page 2 of 4
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analysis was performed by exons amplification and direct
sequencing, after written informed consent from patients
parents. In Patient 1 genotyping disclosed the maternal
c.685C>T transition and the paternal c.756C>A transver-
sion, leading to p.Arg229X and the p.Cys252X nonsense
mutations, respectively (Figure 2A). Both nucleotide sub-
stitutions were previously reported in homozygosity: the
c.685C>T in a Belgian family [4], and the c.756C>A in a
Kurdish patient [3]. In Patient 2 the maternal c.1334delG
microdeletion, leading to the p.G445fsX484 recurrent
mutation and the novel c.691C>T transition were dis-
closed (Figure 2B). The c.691C>T transition, detected in
heterozygosity in the father and in the unaffected younger
brother of the patient, affected the first position of the
codon replacing a hydrophilic arginine residue with the
hydrophobic tryptophan residue (p.Arg231Trp). The
p.Arg231 was previously found substituted by a Gln resi-
due, as the consequence of the c.692G>A transition, in
three Spanish affected siblings, in compound heterozy-
gosity with the c.1334delG mutation, like in our patient
[4]. Nonsense and frameshift mutations, leading to a pre-
mature termination codon, could lead to nonsense medi-
ated mRNA decay and allele loss-of-function [5]. On the
other hand, missense mutations localized at an endofacial
loop of GLUT10, like the p.Arg231Trp, should exert inter-
ference on the conformational changes of the protein nec-
essary for the sugars transport [5,7].
Conclusion
Two novel ATS patients were characterized at clinical and
molecular level. Overall, four ATS unrelated families are
known in Italy so far [[1,6,7,9], this work]. Of the 17
SLC2A10 mutations so far identified, 9 were missense, 4
nonsense and 4 small out-of-frame deletions leading to
premature termination codons. The c.1334delG and the
c.1309G>A mutations are recurrent, as well as the
c.243C>G mutation found in Qatari [11] and Middle
Eastern families [4,5,8]. The mutations here identified
underline the recurrence of known SLC2A10 mutations
among ATS patients, suggesting that these mutations
arose more than one time, or likely should be referred to
a founder effect, as shown for the c.1334delG deletion,
already found in ATS patients from European countries
and showing identical haplotype [4,5]. Among these, of
note, both Italian families were from South Italy [[5], this
work].
On the basis of previous observations and on the reports
of clinical findings of patients carrying the same muta-
tions of ours, no genotype-phenotype correlation can be
drawn. Indeed, neither the type nor the position of muta-
tions correlates with specific manifestations, or with type
and onset of complications. In the patients here reported,
the involvement of major- and medium-sized arteries was
characteristic, though the extravascular manifestations
were mild and not pathognomic for the disorder. Both
patients were suspected as affected with ATS following the
onset of acute respiratory symptoms, caused by hyperten-
sion of pulmonary branches, in the immediate perinatal
period (Patient 1), and in the second infancy, in an appar-
ent otherwise healthy child without a significant clinical
history addressing a precocious diagnosis (Patient 2).
Both conditions were life-threatening events needing
Molecular characterization of the patients by SLC2A10 sequencing on genomic DNA, obtained from whole peripheral blood of the patients, fter writ en informed co sent given by th  parentsFigure 2
Molecular characterization of the patients by SLC2A10 sequencing on genomic DNA, obtained from whole 
peripheral blood of the patients, after written informed consent given by the parents. A) Patient 1 genotyping: the 
c.685C>T transition and the c.756C>A transversion, both in exon 2 and leading to p.Arg229X and the p.Cys252X nonsense 
mutations, respectively B) Chromatograms of mutations identified in Patient 2: the recurrent c.1334delG microdeletion in 
exon 3 and the novel c.691C>T transition in exon 2.Page 3 of 4
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emergency treatments and investigations. Though ATS
prognosis has been recently downsized and thought to be
less severe than initially reported (i.e., a mortality rate up
to 40% before the age of 5 years), death in young age was
referred to respiratory insufficiency, ventricular hypertro-
phy resulting in global heart failure, myocarditis, and
ischemic events leading to organs infarction [2,4]. Among
these causes, pulmonary infections, like the reported
bronchiolitis in Patient 1, playing as trigger events of res-
piratory distress and acute cardiac failure, are thought to
be serious events in young ATS patients [2,12-14].
Our results indicate that patients exhibiting arterial tortu-
osity with mild or without extravascular connective tissue
manifestations should be screened for SLC2A10 gene
mutations.
Further works in the comprehension of the natural history
and on the molecular basis of ATS are needed to add new
insights for diagnosis and prevention strategies for related
complications.
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